Filing Details

Accession Number:
0000885590-10-000014
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-06-03 13:00:00
Reporting Period:
2010-06-01
Filing Date:
2010-06-03
Accepted Time:
2010-06-03 10:18:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
885590 Biovail Corp BVF Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1477625 Paul John Douglas Squires C/O Biovail Corporation
7150 Mississauga Road
Mississauga A6 L5N 8M5
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, No Par Value Acquisiton 2010-06-01 75,033 $10.83 104,721 No 4 M Direct
Common Stock, No Par Value Disposition 2010-06-01 75,033 $14.77 29,688 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, No Par Value Stock Options (right to purchase) Disposition 2010-06-01 75,033 $0.00 75,033 $10.83
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-05-06 2010-06-01 No 4 M Direct
Footnotes
  1. Stock Options were exercised and underlying Common Stock sold pursuant to a 10b5-1 Selling Plan adopted by the Reporting Person on June 29, 2009.
  2. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.61 to $14.92, inclusive. The reporting person undertakes to provide to Biovail Corporation, any security holder of Biovail Corporation, or the staff of the U.S. Securities and Exchange Commission, in each case upon request, full information regarding the number of shares sold at each separate price.